GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Dignitana AB (OSTO:DIGN) » Definitions » Debt-to-Asset

Dignitana AB (OSTO:DIGN) Debt-to-Asset : 0.25 (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Dignitana AB Debt-to-Asset?

Dignitana AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr11.21 Mil. Dignitana AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr0.00 Mil. Dignitana AB's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was kr44.73 Mil. Dignitana AB's debt to asset for the quarter that ended in Mar. 2024 was 0.25.


Dignitana AB Debt-to-Asset Historical Data

The historical data trend for Dignitana AB's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dignitana AB Debt-to-Asset Chart

Dignitana AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.09 0.07 0.33 0.31 0.43

Dignitana AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.17 0.23 0.24 0.43 0.25

Competitive Comparison of Dignitana AB's Debt-to-Asset

For the Medical Devices subindustry, Dignitana AB's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dignitana AB's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Dignitana AB's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Dignitana AB's Debt-to-Asset falls into.



Dignitana AB Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Dignitana AB's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(13.027 + 6.077) / 44.831
=0.43

Dignitana AB's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dignitana AB  (OSTO:DIGN) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Dignitana AB Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Dignitana AB's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Dignitana AB (OSTO:DIGN) Business Description

Traded in Other Exchanges
Address
Traktorgranden 3, Lund, SWE, 226 60
Dignitana AB is a medical technology company, that develops, produces, and markets The DigniCap Scalp Cooling System. It is a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy to improve well-being and quality of life. Geographically, it derives a majority of revenue from the USA.

Dignitana AB (OSTO:DIGN) Headlines

No Headlines